EyeIC's MatchedFlicker is a groundbreaking new technology for monitoring the advent and progression of retinal disease and glaucoma through change detection in time series images.
About EyeIC
EyeIC is a cutting-edge medical technology firm dedicated to commercializing imaging technologies for medical applications.
EyeIC was founded around patented technology developed by Dr. Jeffrey Berger and colleagues at the University of Pennsylvania's School of Medicine who were interested in the application of information technology to medical imaging. While the initial uses are in ophthalmology, MatchedFlicker has broader applications throughout medicine.
Management
- Philip Heifetz – President and CEO
- Steve Bakanov, MS, Ph.D. – Technology Director
Investors
- Launch Capital
- MentorTech Ventures
- Ben Franklin Technology Partners
Currently, EyeIC is accepting inquiries from qualified investors who are interested in growing a technology brand backed by rigorous scientific research. Please contact us if you'd like to schedule an appointment with one of our representatives to discuss this unique opportunity.